Timing of teriparatide for postmenopausal osteoporosis
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.
This study tests whether giving teriparatide (a daily injection that helps build bone) at different times of day makes it work better for women with postmenopausal osteoporosis and very low bone density. If you qualify, you might get the medicine either in the morning or evening, and researchers will track how your bone density changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 70 years old.
- You have gone through menopause at least 5 years ago.
- Your bone density score (T-score) is -3.0 or lower at the spine or hip.
- Your vitamin D level is at least 20 ng/mL (can be improved with supplements).
- You have not had any fractures, and you have not used certain bone medications recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of two bone-building drugs (romosozumab and teriparatide) in postmenopausal women with osteoporosis who are at high risk for fractures. The goal is to see if the combination strengthens bones faster and better than either drug alone.
This study tests a new version of a medicine called abaloparatide (used for bone health) to see if it works the same as the approved version (Tymlos). It is for healthy adults aged 40–65 who are willing to stay at the clinic for a few days and have blood tests.
This study is a follow-up for people who completed a previous precision medicine trial for osteoporosis. It will monitor your bone health to see how well the treatment is working over time.
This trial tests whether a specific exercise program (circuit training) can improve bone density in women after menopause who have low bone mass. It may help strengthen bones and reduce fracture risk.
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
This study looks at how the natural aging of the body might affect how well bone-strengthening medications work for osteoporosis. If you are about to start one of these medications, the study will track your bone density over time to see how your response may differ based on your 'biological age.'
Hear when a new Circadian Rhythm Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.